Author: Thomas H. McGlashanPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 146
Book Description
The Documentation of Clinical Psychotropic Drug Trails
Author: Thomas H. McGlashanPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 146
Book Description
The Documentation of Clinical Psychotropic Drug Trials: Sample output package
Author: National Institute of Mental Health (U.S.). Psychopharmacology Research BranchPublisher:
ISBN:
Category : Antidepressants
Languages : en
Pages : 140
Book Description
The Documentation of Clinical Psychotropic Drug Trials
Author: National Institute of Mental Health (U.S.)Publisher:
ISBN:
Category : Antidepressants
Languages : en
Pages : 198
Book Description
The Documentation of Clinical Psychotropic Drug Trials
Author: National Institute of Mental Health (U.S.). Psychopharmacology Research BranchPublisher:
ISBN:
Category : Psychopharmacology
Languages : en
Pages : 140
Book Description
The Documentation of Clinical Psychotropic Trug Trials
Author: National Institute of Mental Health (U.S.)Publisher:
ISBN:
Category :
Languages : en
Pages : 196
Book Description
Transforming Clinical Research in the United States
Author: Institute of MedicinePublisher: National Academies Press
ISBN: 0309163358
Category : Medical
Languages : en
Pages : 151
Book Description
An ideal health care system relies on efficiently generating timely, accurate evidence to deliver on its promise of diminishing the divide between clinical practice and research. There are growing indications, however, that the current health care system and the clinical research that guides medical decisions in the United States falls far short of this vision. The process of generating medical evidence through clinical trials in the United States is expensive and lengthy, includes a number of regulatory hurdles, and is based on a limited infrastructure. The link between clinical research and medical progress is also frequently misunderstood or unsupported by both patients and providers. The focus of clinical research changes as diseases emerge and new treatments create cures for old conditions. As diseases evolve, the ultimate goal remains to speed new and improved medical treatments to patients throughout the world. To keep pace with rapidly changing health care demands, clinical research resources need to be organized and on hand to address the numerous health care questions that continually emerge. Improving the overall capacity of the clinical research enterprise will depend on ensuring that there is an adequate infrastructure in place to support the investigators who conduct research, the patients with real diseases who volunteer to participate in experimental research, and the institutions that organize and carry out the trials. To address these issues and better understand the current state of clinical research in the United States, the Institute of Medicine's (IOM) Forum on Drug Discovery, Development, and Translation held a 2-day workshop entitled Transforming Clinical Research in the United States. The workshop, summarized in this volume, laid the foundation for a broader initiative of the Forum addressing different aspects of clinical research. Future Forum plans include further examining regulatory, administrative, and structural barriers to the effective conduct of clinical research; developing a vision for a stable, continuously funded clinical research infrastructure in the United States; and considering strategies and collaborative activities to facilitate more robust public engagement in the clinical research enterprise.
Practical Psychopharmacology
Author: Joseph F. GoldbergPublisher: Cambridge University Press
ISBN: 1108450741
Category : Medical
Languages : en
Pages : 611
Book Description
A practical guide translating clinical trials findings, across major psychiatric disorders, to devise tailored, evidence-based treatments.
Neuroscience Trials of the Future
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309442583
Category : Medical
Languages : en
Pages : 111
Book Description
On March 3-4, 2016, the National Academies of Sciences, Engineering, and Medicine's Forum on Neuroscience and Nervous System Disorders held a workshop in Washington, DC, bringing together key stakeholders to discuss opportunities for improving the integrity, efficiency, and validity of clinical trials for nervous system disorders. Participants in the workshop represented a range of diverse perspectives, including individuals not normally associated with traditional clinical trials. The purpose of this workshop was to generate discussion about not only what is feasible now, but what may be possible with the implementation of cutting-edge technologies in the future.
Author: 
Author: Jerome Levine